Market: NASD |
Currency:
Address:
📈 HEAL Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for HEAL
No earnings history available for this symbol.
📰 Related News & Research
-
UG Healthcare FY25 Results: Net Loss Narrows 37%, Revenue Up 25% with Distribution Expansion—No Dividend Announced 1
August 28, 2025
UG Healthcare Corporation Limited FY25 Financial Results Analysis UG Healthcare Corporation Limited (“UG Healthcare”) has released its financial results for the fiscal year ended 30…
-
Sunway Berhad 2Q25 Results: Strong Property Sales, Healthcare Listing Catalyst & RM5.70 Target Price – UOB Kay Hian Analyst Report
August 28, 2025
Broker: UOB Kay Hian Date of Report: Thursday, 28 August 2025 Sunway Berhad Q2 2025 Financial Analysis: Missed Expectations but Strong Launch Pipeline and Healthcare…
-
Alliance Healthcare Group FY2025 Results: Revenue Up 13.4%, S$206,390 Final Dividend Declared, Segment Performance & Outlook 283536
August 23, 2025
Alliance Healthcare Group Limited: FY2025 Results Analysis Alliance Healthcare Group Limited has released its unaudited condensed interim financial statements for the twelve months ended 30…
-
Ping An Healthcare (1833 HK) Delivers Strong 1H25 Results: Revenue & Profit Surge, AI Synergies Drive Growth – Target Price HK$19.00
August 21, 2025
Broker: UOB Kay Hian Date of Report: August 21, 2025 Ping An Healthcare and Technology Delivers Blockbuster 1H25: AI, Synergies, and Senior Care Fuel Growth…
-
JBM Healthcare (2161 HK): Po Chai Pills Rebranding & Marketing Drive Set to Boost Growth, Attractive Dividend Yield for FY26
August 19, 2025
UOB Kay Hian Date of Report: Tuesday, 19 August 2025 Hong Kong Small-Mid Caps: JBM Healthcare, Plover Bay Technologies & Launch Tech—Growth, Innovation, and Valuation…
-
JBM Healthcare (2161 HK): Po Chai Pills New Packaging, Strong FY26 Dividend Yield & Growth Outlook – UOB Kay Hian Report August 2025
August 19, 2025
UOB Kay Hian Date of Report: 19 August 2025 Greater China Small-Mid Cap Monthly: Key Investment Opportunities in JBM Healthcare, Plover Bay Technologies, and Launch…
-
Clearbridge Health Completes S$1.98 Million Share Placement and Warrant Issue to Boost Capital 1
August 18, 2025
Clearbridge Health Completes Massive Share Placement and Warrant Issue Clearbridge Health Completes Massive Share Placement with Free Warrants: What Retail Investors Must Know Key Highlights…
-
Clearbridge Health Completes Placement of 990 Million Shares and 660 Million Free Warrants on SGX Catalist Board 1
August 18, 2025
Clearbridge Health Completes Massive Share Placement and Warrant Issue: What Retail Investors Must Know Clearbridge Health Completes Massive Share Placement and Warrant Issue: What Retail…
-
Clearbridge Health Secures S$1.98 Million in Strategic Placement, Advances Debt-Free Growth and US$330M Elpis Biopharma Acquisition 123
August 18, 2025
Clearbridge Health Secures S\$1.98 Million in Strategic Placement, Sets Sights on US\$330M Biopharma Acquisition: What Retail Investors Need to Know Key Points for Investors Clearbridge…
-
Parkway Life REIT 1H25 Results – Strong Growth, European Expansion, and Defensive Healthcare Focus
August 18, 2025
Broker: UOB Kay Hian Date of Report: 18 August 2025 Parkway Life REIT: Robust Growth and Strategic Expansion into Europe Bolster Defensive Strength Overview: Defensive…
🔍 View more Reports